You are here
Inflammatory Bowel Disease
The PMC reviewed relevant performance measures and makes the following recommendations.
ID# QPP 271
Percentage of patients aged 18 years and older with an inflammatory bowel disease encounter who were prescribed prednisone equivalents greater than or equal to 10 mg/day for 60 or greater consecutive days or a single prescription equating to 600mg prednisone or greater for all fills and were documented for risk of bone loss once during the reporting year or the previous calendar year.
Date Reviewed: November 19, 2017
ID# PQRS 275
Percentage of patients aged 18 years and older with a diagnosis of inflammatory bowel disease who had Hepatitis B virus status assessed and results interpreted within one year prior to receiving a first course of anti-TNF therapy.
Date Reviewed: November 7, 2015